What is Arvinas's G&A?

Arvinas (ARVN) reported G&A of $19.1M in Q1 2026.

How has Arvinas's G&A changed year-over-year?

Arvinas's G&A decreased by 28.2% year-over-year, from $26.6M to $19.1M.

What is the long-term trend for Arvinas's G&A?

Over 4 years (2021 to 2025), Arvinas's G&A has grown at a 11.7% compound annual growth rate (CAGR), from $61.5M to $95.9M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Arvinas ARVN G&A

G&A at other companies

Nurix Therapeutics, Inc.NRIX

$14.61M+25.4%

Kymera TherapeuticsKYMR

$20.36M+25.1%

Monte Rosa Therapeutics, Inc.GLUE

$10.18M+16.9%

Relmada Therapeutics, Inc.RLMD

$11.37M+81.5%

Nuvectis Pharma, Inc.NVCT

$2.15M+14.1%

ArriVent BioPharma, Inc.AVBP

$8.49M+54.9%

Segments

By segment

See full

Reportable Segment$19.1M-28.2%

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's G&A?: Arvinas (ARVN) reported G&A of $19.1M in Q1 2026.
How has Arvinas's G&A changed year-over-year?: Arvinas's G&A decreased by 28.2% year-over-year, from $26.6M to $19.1M.
What is the long-term trend for Arvinas's G&A?: Over 4 years (2021 to 2025), Arvinas's G&A has grown at a 11.7% compound annual growth rate (CAGR), from $61.5M to $95.9M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.